On December 13, 2023, Prelude Therapeutics Incorporated closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 USD | -8.35% | -3.37% | -12.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.65% | 205M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Prelude Therapeutics Incorporated announced that it has received $24.999997 million in funding